| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $8.79T | $8.17T | $8.51T | $4.28T | $2.11T | $3.50T |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $962.95B | $826.91B | $751.19B | $692.88B | $611.33B | $623.73B |
| Operating Income | – | – | – | – | – | – |
| Interest Expense | – | – | $4.56T | $2.18T | $374.13B | $467.94B |
| Tax Expense | $359.61B | $199.53B | $425.12B | $35.14B | -$141.02B | $210.72B |
| Net Income | $1.16T | $593.39B | $912.47B | -$14.01B | -$104.72B | $581.76B |
| EPS (basic) | 466.1600 | 234.5500 | 359.7000 | -5.5200 | -41.2800 | 229.2700 |
| EPS (diluted) | 466.0900 | 234.5200 | 359.6500 | -5.5200 | -41.2800 | 229.2600 |
| Shares (diluted) | $2.48B | $2.53B | $2.54B | $2.54B | $2.54B | $2.54B |